ANS Adrenergic Flashcards
acebutolol
Beta 1 selective receptor antagonists. Class II antiarrhythmic fast Na+ blocker.
TX. prohylaxis post-MI and supraventricular tachyarrhythmias. angina, HT,
less effect vasospasm, bronchospasm, uterus, metabolism.Safer in asthma, diabetes, peripheral vascular disease. ISA: intrinsic sympatomimetic activity as partial agonist with less bradycardia (-b1) and slight vaso/broncho dilation (-b2) and no change in lipids (-b2) adv. some sedation
Albuterol
Beta 2 agonist Tx asthma
Alpha 1 receptor activation effects
Gq (phospholipase C, Ip3, DAG, Ca+2) eye mydriasis: radial dilator contraction (no cycloplegia!) arterioles contraction veins contraction bladder trigone and sphincter contraction male sex organs vas deferens ejaculation liver glycogenolysis kidney DECREASED renin release
Alpha 1 effects on HR and BP
arterioles contraction veins contraction Increase TPR and BP potential bradycardia reflex CO may decrease, offset by increase venous return NO-change in pulse pressure (systolic-diastolic) *phenylephrine and methoxamine
Alpha 2 effects on HR and BP
prejunctional nerve terminals *DECREASE NE* platelets aggregation decreased CNS SANS prejunctional outflow used in mild to moderate HTN clonidine, methyldopa
Alpha 2 receptor activation effects
Gi (decrease adenylyl cyclase, cAMP) **prejunctional nerve terminals DECREASE NE release** platelets aggregation pancrease DECREASE insulin
amphetamines
indirect acting adrenergic receptor agonists releaser displace NE from mobile pool (neurojunction) psychostimulant do to central release of DA, NE, 5HT Tx. methyl phenidate in narcolepsy and ADHD
Alpha receptor antagonist
decrease TPR, mean BP potential reflex tachycardia, salt/water retention tx. HT, pheochromocytoma, BPH phentolamine, phenoxybenzamine prazosin, doxazosin, terazosin, tamsulosin yohimbine, mirtazapine
atenolol
Beta 1 selective receptor antagonists
TX. angina, HTN, post-MI
adv. Blood lipids increases LDL and TGs, sexual dysfunction, cardiovascular depression. Caution (but safer) in asthma, vasospastic disorders, diabetics (decreases insulin secretion), pregnancy
No sedation
Baroreceptor reflex
Increased BP elicits baroreceptor discharge to cardiovascular center. Nn blockers to block reflex at ganglionic synapse Nm2 block reflex bradycardia HR (vagal tone) B1 block reflex tachycardia HR, contractile force and vasoconstriction.
Beta agonist effects on HR and BP
beta 1: SA node positive chronotropy AV node positive dromotropy atrial/ventricular muscle positive inotropy His-purkinje positive dromotrophy beta 2: blood vessel vasodilate (non-innervated) beta 2 decrease BP (decrease TPR) beta 1 increase HR (increase SV, CO, pulse pressure= systolic-diastolic) isoproterenol, dobutamine salmeterol, albuterol, terbutaline, ritodrine
Beta receptor antagonists
Beta 1 blockade: decreased HR, SV, CO, renin, aqueous humour production beta 2 blockade: may precipitate bronchospasm, vasospasm block glycogenolysism gluconeogenesis increase LDL and TGs Chronic use leads to receptor upregulation; therefor important to taper use to avoid rebound of endogenous amines. acebutolol, atenolol, metoprolol, pindolol, propranolol, timolol labetalol, carvedilol, sotalol
Beta1 receptor activation effects
Gs (increase adenylyl cyclase, cAMP) SA node positive chronotropy AV node positive dromotropy atrial/ventricular muscle positive inotropy His-purkinje positive dromotrophy kidney increased renin
Beta2 receptor activation effects
Gs (increase adenylyl cyclase, cAMP) mostly non-innervated blood vessels vasodilate uterus relaxation brochioles dilation skeletal glycogenolysis (tremor) liver glycogenolysis pancrease increase insulin (metabolize fat and gluconeogenesis)
carvedilol
combined alpha 1 and beta blocker
tx. CHF
Catechol-O-methyltransferase (COMT)
degrades NE at synapse
Clonidine
alpha 2 agonists
- decreases CNS SANS prejunctional outflow of NE
- decrese TPR and HR
TX. mild to moderate HTN and opiate withdrawl
ADV. CNS depression, edema.
DI: TCAs decrease antiHTN effets
Cocaine
indirect acting adrenergic receptor agonists reuptake inhibitor NE (neurojunction)
Closed Angle Glaucoma
Acute or Chronic increased introccular pressure due to blockage of cannal of schlemm Tx. SURGERY. cholinomimetics, carbonic anhydrase inhibitors, mannitol. C/I alpha 1 agonist (myadriasis further closing the angle cannal)
dobutamine
B1>B2 agonist
TX. CHF
Dopamine
sympathomimetic. vasodilate renal, mesenteric, coronary vascular beds
Synthesized from Tyr hydroxylase metabolite: homovanillic acid
- Dopamine will stimulate D1(Gs) at low dose,
- beta 1 at medium dose alpha 1 at high dose
TX. CHF
doxazosin
Alpha 1 selective receptor antagonist
- decrease arteriolar, venous, sphincter resistance
TX. HTN, BPH (decrease urinary frequency and nocturia) [good effect on lipid profil]
ADV reflex tachycardia, first dose effect, orthostatic hypotension, urinary incontenence.
Ephedrine
indirect acting adrenergic receptor agonists releaser displace NE from mobile pool (neurojunction) tx. cold medication
Epinephrine
Synthesized from Tyr from Dopa/NE by adrenal medula. metabolite: vanillylmandelic acid (VMA) mixed acting agonist low dose beta > alpha effects: b1: increased HR, SV, CO, pulsepressure. b2: decreased TPR, BP medium dose opposing alpha 1 effect of increased TRP, BP high dose effect similar to NE alpha > beta with potential reflex bradycardia. *alpha1 blocker to reverse HT in OD to eliminate vasatone and unmask beta 2 effects* Tx. cardiac arrest, adjunct to local anesthetic, hypotension, anaphylaxis, asthma
esmolol
Class II antiarrhythmic fast Na+ blocker.
IV.
TX. acute supraventricular tachyarrhythmias
Fenoldopam
D1 agonist Tx severe hypertension at high dose D1, beta1, alpha1 agonist as dose increases
Glucagon receptors of the heart
Gs coupled glucagon receptors positive inotropic and chronotropic effects on the heart *beta blockers in glucagon OD*
Guanethidine
act directly on the granule of NE in perjunctional nerve, decreasing NE release
isoproterenol
B1=B2 agonist
TX. bronchospasm, heart block, bradyarrythmias
Adv. flushing, angina, arrhythmias
labetalol
combined alpha 1 and beta blocker tx. CHF
methoxamine
alpha 1 agonist paroxysmal atrial tachycardia through vagal reflex
methyldopa
alpha 2 agonists
- decreases CNS SANS prejunctional outflow of NE
- decrese TPR and HR
TX. mild to moderate HTN (safe in pregnancy)
ADV. CNS depression, edema, positive coombs test.
DI: TCAs decrease antiHTN effets
metoprolol
Beta 1 selective receptor antagonists
TX. angina, HTN, post-MI
adv. some sedative and blood lipids increases LDL and TGs, sexual dysfunction, cardiovascular depression. Caution (but safer) in asthma, vasospastic disorders, diabetics (decreases insulin secretion)
Monoamine Oxidase (MAO)
inactivates NE in the prejunctional nerve terminal MAO-a: liver and anywhere metabolizes NE, 5HT, tyramine MAO-b: brain metabolizes DA
mirtazapine
Alpha 2 selective receptor antagonist tx. antidepressant
non-selective Adrenergic effects on receptors at varying doses
non selective adrenergics responses at low dose beta > alpha at high dose alpha > beta Dopamine will stimulate D1 at low dose, beta 1 at medium dose alpha 1 at high dose
Norepinephrine
Synthesized from Tyr from Dopa within nerve ending vessicles. stored as granules metabolite: vanillylmandelic acid (VMA)
mixed acting agonist (alpha 1/2, beta1)
increase TRP, BP, HR, SV, CO, increase pulse pressure=systolic-diastolic
potential reflex bradycardia no effect Beta2
Tx. cardiac arrest, adjunct to local anesthetic, hypotension
Open angle glaucoma
chronic painless increased intraocular pressure due to decreased reabsorption of aqueous humour tx. beta blocker - timolol (decrease NE at ciliary epithelial tereby decreasing fluid formation) M3 agonist -pilocarpine (contract ciliary muscle to increase drainage) AchE Inhibitor - echothiophate
phenoxybenzamine
Alpha receptor noncompetitive antagonist (Vmax decreased, Km unchanged)
phentolamine
Alpha receptor competitive antagonist (Vmax same, Km increased)
phenylephrine
alpha 1 agonist nasal decongestant and opthalmic myadriasis (without cycloplegia)
pindolol
non selective beta receptor antagonists
ISA: intrinsic sympatomimetic activity as partial agonist with less bradycardia (-b1) and slight vaso/broncho dilation (-b2) and no change in lipids (-b2)
tx. angina, HTN, post-MI
adv. some sedation
Prazosin
Alpha 1 selective receptor antagonist
- decrease arteriolar, venous, sphincter resistance
TX. HTN, BPH (decrease urinary frequency and nocturia) [good effect on lipid profil]
ADV reflex tachycardia, first dose effect, orthostatic hypotension, urinary incontenence.
propranolol
non selective beta receptor antagonists. and Class II antiarrhythmic fast Na+ blocker.
TX. prohylaxis post-MI, supraventricular tachyarrhythmias, HTN
tx. angina, HT, post-MI, class II antiarrhythmic, migraine, thyrotoxicosis, performance anxiety, essential tremor
adv. ++sedative and blood lipids (-b2), increases LDL and TGs, sexual dysfunction, cardiovascular depression. Caution in asthma, vasospastic disorders, diabetics (decreases insulin secretion)
Reserpine
reduce NE levels in the prejunctional terminal by inhibiting granule reuptake
Ritodrine
Beta 2 agonist Tx premature labour (relax uterus)
Salmeterol
Beta 2 agonist Tx asthma
sotalol
combined K+ channel and beta blocker
Sympathetic autonomic Muscarinic Ach
Sweat glands, piloerector muscles
tamsulosin
Alpha 1 selective receptor antagonist
terazosin
Alpha 1 selective receptor antagonist
- decrease arteriolar, venous, sphincter resistance
TX. HTN, BPH (decrease urinary frequency and nocturia) [good effect on lipid profil]
ADV reflex tachycardia, first dose effect, orthostatic hypotension, urinary incontenence.
Terbutaline
Beta 2 agonist Tx asthma
timolol
non selective beta receptor antagonists adv. +sedative and blood lipids (-b2) tx. angina, HT, post-MI, open angle glaucoma
Tricyclic antidepressants
indirect acting adrenergic receptor agonists reuptake inhibitor NE (in part) (neurojunction)
Tyramine
indirect acting adrenergic receptor agonists (red wine, cheese) releaser displace NE from mobile pool (neurojunction) oral bioavail limited by MAO in GI (MAO inhibitors can lead to hypertensive crisis)
yohimbine
Alpha 2 selective receptor antagonist tx. postural hypotension and impotence